总部位于美国华盛顿的创新型初创公司HiLabs近日宣布，其在B轮融资中成功筹集了3900万美元。本轮融资由知名投资机构Eight Roads Ventures和Denali Growth Partners共同领投，F-Prime Capital参与跟投。这一资金注入将为HiLabs的进一步发展注入强大动力。
HiLabs专注于利用人工智能技术进行医疗数据管理，旨在为医疗行业提供高效、精准的解决方案。通过其先进的AI平台，HiLabs能够帮助医疗机构更好地分析、解读和利用海量的医疗数据，从而提升诊疗效率和患者护理质量。
此次筹集的资金将主要用于三个方面：首先，HiLabs计划加大在技术研发上的投入，以持续优化其AI算法和数据分析能力；其次，公司将扩大招聘规模，吸引更多的技术专家和行业人才，以增强团队实力；最后，HiLabs将着力扩展产品线，满足更多医疗机构和患者对于数据驱动医疗服务的需求。
HiLabs的B轮融资成功，不仅反映出市场对AI在医疗领域应用的广泛认可，也彰显了投资者对其未来发展的信心。随着医疗数据的快速增长和AI技术的日益成熟，HiLabs有望在医疗数据解决方案领域占据重要地位，推动全球医疗行业的数字化转型。
英语如下：
**News Title:** “AI Medical Data Company HiLabs Secures $39 Million in Series B Funding, Accelerates Technology and Team Expansion”
**Keywords:** AI Medical, HiLabs, $39 Million Funding
**News Content:**
**Title:** AI Medical Data Solutions Provider HiLabs Closes $39 Million Series B Financing Round
Innovative startup HiLabs, headquartered in Washington, USA, recently announced that it has successfully raised $39 million in its Series B funding round. The round was co-led by prominent venture capital firms Eight Roads Ventures and Denali Growth Partners, with participation from F-Prime Capital. This injection of capital is set to fuel HiLabs’ accelerated growth.
Specializing in AI-driven medical data management, HiLabs aims to provide efficient and precise solutions to the healthcare industry. Through its advanced AI platform, the company enables healthcare institutions to better analyze, interpret, and leverage vast amounts of medical data, thereby enhancing diagnostic efficiency and patient care quality.
The funds raised will primarily be allocated to three areas: Firstly, HiLabs intends to increase investment in research and development to continually optimize its AI algorithms and data analytics capabilities. Secondly, the company plans to expand its workforce, attracting more technical experts and industry professionals to strengthen its team. Lastly, HiLabs will focus on broadening its product offerings to cater to the growing demands for data-driven healthcare services from medical institutions and patients alike.
The successful Series B funding not only underscores the widespread recognition of AI applications in healthcare but also demonstrates investors’ confidence in HiLabs’ future prospects. As medical data continues to proliferate and AI technology matures, HiLabs is poised to play a significant role in the medical data solutions sector, driving the digital transformation of the global healthcare industry.
【来源】https://yourstory.com/2024/03/funding-hilabs-39-m-series-b-eight-roads-denali-growth-partners
Views: 4